Author： Cervenakova L.
Publisher： Elsevier
ISSN： 1246-7820
Source： Transfusion Clinique et Biologique, Vol.8, Iss.3, 2001-06, pp. : 260-260
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inactivation of TSE agents: safety of blood and blood-derived products
By Taylor D.M.
Transfusion Clinique et Biologique, Vol. 10, Iss. 1, 2003-02 ,pp. :
Access to resources
Recommend
Distribution of normal prion protein in blood
By MacGregor I. Drummond O. Turner M. Barclay R. Prowse C.
Transfusion and Apheresis Science, Vol. 22, Iss. 1, 2000-02 ,pp. :
Distribution of normal prion protein in blood
By MacGregor I. Drummond O. Turner M. Barclay R. Prowse C.
Transfusion Science, Vol. 22, Iss. 1, 2000-02 ,pp. :
Safety Evaluation of Recombinant Human Interleukin-4 II. Clinical Studies
By Leach M.W. Rybak M.E. Rosenblum I.Y.
Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. :